Viewing Study NCT06485466


Ignite Creation Date: 2025-12-24 @ 4:01 PM
Ignite Modification Date: 2026-01-02 @ 12:49 PM
Study NCT ID: NCT06485466
Status: RECRUITING
Last Update Posted: 2024-07-03
First Post: 2024-06-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: TACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma
Sponsor: Guohui Xu
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module